公开(公告)号：US20230253109A1

公开(公告)日：2023-08-10

申请号：US18011211

申请日：2021-03-17

申请人： HITACHI, LTD.

发明人： Takashi ISHIGAKI ,  Minoru SAKAIRI ,  Mayumi ABE

IPC分类号： G16H50/20 ,  G16B20/00 ,  G16B40/20

CPC分类号： G16H50/20 ,  G16B20/00 ,  G16B40/20

摘要： A cancer screening device includes a cancer screening model generation unit configured to construct, as a cancer screening model, clinical data that is results of cancer screening for a plurality of subjects including cancer patients and healthy subjects, and metabolite exhaustive data that is a result of LC/MS analysis of first urine specimens collected from these subjects and is information related to amounts of a plurality of metabolites in the first urine specimens, a second acquisition unit configured to acquire sample data that is a result of LC/MS analysis of a second urine specimen collected from a second subject who is different from the first subjects, and a screening processing unit configured to estimate the cancer state of the second subject by applying an amount of metabolite in the sample data to the cancer screening model, and an output processing unit configured to output the estimated state of the cancer.

公开(公告)号：US20200150124A1

公开(公告)日：2020-05-14

申请号：US16675109

申请日：2019-11-05

申请人： National University Corporation Nagoya University ,  Hitachi, Ltd.

发明人： Hiroo UCHIDA ,  Akinari HINOKI ,  Minoru SAKAIRI ,  Mayumi ABE

IPC分类号： G01N33/574 ,  G01N30/06 ,  G16B40/10 ,  G16H50/30

摘要： Provided are a method, an apparatus, and a kit for detecting a neuroblastoma in a subject and/or for monitoring a therapeutic effect on the neuroblastoma, by measuring a urinary tumor marker(s) in a sample from the subject.

公开(公告)号：US20200081015A1

公开(公告)日：2020-03-12

申请号：US16551780

申请日：2019-08-27

申请人： HITACHI, LTD.

发明人： Minoru SAKAIRI ,  Mayumi ABE ,  Taku NAKAMURA

IPC分类号： G01N33/68 ,  G01N30/72 ,  G01N33/493

摘要： A cancer screening processor includes a database which stores a sample information database storing information on a number of dispensed samples of urine sent from subjects; the sample dispensed for a cancer type which the subject desire a screening, a center selection unit which selects an analysis center C2 for each of cancer type to be analyzed by using a urinary tumor marker; the analysis center C2 receiving a sample container including dispensed sample on the basis of the cancer type and information from analysis centers, and a processing unit which counts a number of the sample containers on the basis of the sample information database, and performs a process step of sending the sample container to the analysis center when the number of the sample containers becomes equal to a number in the information from the analysis center.